When is a PrEP candidate ready for phase 3?

Craig Hendrix

doi:10.1016/S2352-3018(16)30162-X

When is a PrEP candidate ready for phase 3?

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	e551-e553
Journal	The Lancet HIV
Volume	3
Issue number	12
DOIs	https://doi.org/10.1016/S2352-3018(16)30162-X
State	Published - Dec 1 2016

ASJC Scopus subject areas

Epidemiology
Immunology
Infectious Diseases
Virology

Access to Document

10.1016/S2352-3018(16)30162-X

Cite this

@article{dfd40897f8064ed09ce8e10713f7c28d,

title = "When is a PrEP candidate ready for phase 3?",

author = "Craig Hendrix",

note = "Funding Information: I have received research funding from GSK/ViiV managed through Johns Hopkins University and perform research on pharmaceutical products from Gilead, Janssen, and International Partnership for Microbicides funded by NIH and the Gates Foundation.",

year = "2016",

month = dec,

day = "1",

doi = "10.1016/S2352-3018(16)30162-X",

language = "English (US)",

volume = "3",

pages = "e551--e553",

journal = "The Lancet HIV",

issn = "2352-3018",